Memorial Sloan Kettering, N.Y.(4/06)

Neuigkeiten aus dem New Yorker Krebs-Zentrum.
April 2006 Lately@mskcc.org

http://www.mskcc.org/Lately@MSKCC

Welcome to Lately@MSKCC,

Memorial Sloan-Kettering Cancer Center’s monthly

enewsletter.

INCLUDED IN THIS ISSUE

============================================================

* MRI Screening for Women at High Risk of Breast Cancer

* Yankees Universe Fund Unveiled

* Pediatric Patient Story – Perry Zimmerman

* An Interview with Kathleen M. Foley

* Protein Regulates Quiescent Blood Stem Cells That Are

Linked to Enhanced Recovery from Radiation and

Chemotherapy

* Investigators Show How Key Growth Factor Influences Immune

System

* The Latest in Colorectal Cancer: Screening, Diagnosis, and

Treatment

============================================================

************************************************************

MAKE A GIFT – http://www.mskcc.org/MakeAGift

************************************************************

MRI Screening for Women at High Risk of Breast Cancer

A woman with a family history of breast cancer often lives

under a cloud of anxious uncertainty, wondering if the

disease that affected her mother, sister, or other

first-degree relative may strike her as well. Fortunately,

a number of studies suggest that women at high risk for

developing breast cancer may benefit from magnetic

resonance imaging (MRI) screening, providing these women

with a new option they can use to help address their

concerns.

http://www.mskcc.org/65116

WHAT’S NEW AT MSKCC.ORG

———————–

Yankees Universe Fund Unveiled

The New York Yankees and Memorial Sloan-Kettering Cancer

Center have joined together to support the Center’s

programs in pediatric patient care, research, and

education by creating the New York Yankees Universe fund.

http://www.mskcc.org/63978

Pediatric Patient Story – Perry Zimmerman

To meet Perry Zimmerman, you would think you’re meeting a

typical, albeit cute and precocious, five-year-old. What

you wouldn’t know was that Perry has faced and conquered

more life-threatening obstacles in her short life than

most people could even begin to imagine. Born with a rare

cancer of the eye known as retinoblastoma that spread to

her brain, Perry successfully fought through five cycles

of chemotherapy and one stem cell transplant at Memorial

Sloan-Kettering to overcome the cancer. After such an

arduous journey made by such a little girl, it is

understandable that her parents, Larry and Anne Zimmerman,

think of her as their little miracle.

http://www.mskcc.org/63160

An Interview with Kathleen M. Foley

Memorial Sloan-Kettering neurologist Kathleen M. Foley

focuses on the assessment and treatment of pain in cancer

patients, as well as on developing policies for pain and

palliative care worldwide. She is the incumbent of The

Society of Memorial Sloan-Kettering Cancer Center Chair

and former Chief of the Pain and Palliative Care Service.

Dr. Foley chairs the International Association for Hospice

and Palliative Care and is a member of the Institute of

Medicine of the National Academies.

http://www.mskcc.org/63672

RESEARCH AT MEMORIAL SLOAN-KETTERING

————————————

Protein Regulates Quiescent Blood Stem Cells That Are Linked

to Enhanced Recovery from Radiation and Chemotherapy

Memorial Sloan-Kettering scientists and colleagues have

uncovered new information about what orchestrates the

complex balance between blood stem cells and mature blood

cells, a relationship that is often disrupted in leukemia.

The results, published in the March issue of Cancer Cell,

will lead to a better understanding of the behavior of

leukemic cells and may have vital clinical applications

for patients recovering from chemotherapy, radiation

therapy, or bone marrow transplantation.

http://www.mskcc.org/63981

Investigators Show How Key Growth Factor Influences Immune

System

Memorial Sloan-Kettering investigators Joan Massaguý and

Dori A. Thomas have published a paper showing how the

protein called transforming growth factor-beta (TGF-ý)

allows tumor cells to escape killing by the immune system.

TGF-ý has been a well-studied cellular protein in cancer

research because it can act as either an inhibitor or a

promoter of cell growth.

http://www.mskcc.org/63671

CANCER INFORMATION & SCREENINGS

——————————-

The Latest in Colorectal Cancer: Screening, Diagnosis, and

Treatment

On Thursday May 4th, join Memorial Sloan-Kettering

physicians — Sidney J. Winawer, MD, Attending Physician,

Gastroenterology and Nutrition Service; Martin R. Weiser,

MD, Assistant Attending Surgeon, Colorectal Service; and

Leonard B. Saltz, MD, Attending Physician — for an

overview of colorectal cancer.

http://www.mskcc.org/63211

************************************************************